DBV Technologies SA – (NASDAQ:DBVT) – Stock analysts at Jefferies Group issued their Q1 2018 earnings per share (EPS) estimates for shares of DBV Technologies in a research report issued to clients and investors on Thursday. Jefferies Group analyst E. Yang forecasts that the company will post earnings per share of ($1.03) for the quarter. Jefferies Group has a “Buy” rating and a $51.00 price objective on the stock. Jefferies Group also issued estimates for DBV Technologies’ Q2 2018 earnings at ($0.98) EPS, Q3 2018 earnings at ($1.03) EPS and Q4 2018 earnings at ($1.08) EPS.
DBVT has been the topic of several other research reports. ValuEngine cut shares of DBV Technologies from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. Zacks Investment Research upgraded shares of DBV Technologies from a “hold” rating to a “buy” rating and set a $32.00 target price on the stock in a report on Tuesday, October 24th. BidaskClub cut shares of DBV Technologies from a “sell” rating to a “strong sell” rating in a report on Wednesday, December 6th. HC Wainwright reiterated a “buy” rating and set a $50.00 price target on shares of DBV Technologies in a research note on Monday, October 23rd. Finally, JMP Securities assumed coverage on shares of DBV Technologies in a research note on Friday, November 17th. They set an “outperform” rating on the stock. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $49.63.
A number of hedge funds and other institutional investors have recently made changes to their positions in DBVT. Janus Henderson Group PLC bought a new stake in DBV Technologies in the 2nd quarter valued at $90,724,000. Jennison Associates LLC increased its holdings in shares of DBV Technologies by 86.4% in the 2nd quarter. Jennison Associates LLC now owns 1,002,067 shares of the company’s stock worth $35,784,000 after buying an additional 464,341 shares during the last quarter. Citadel Advisors LLC bought a new stake in shares of DBV Technologies in the 3rd quarter worth about $7,794,000. Point72 Asset Management L.P. bought a new stake in shares of DBV Technologies in the 3rd quarter worth about $2,190,000. Finally, Sectoral Asset Management Inc increased its holdings in shares of DBV Technologies by 34.2% in the 2nd quarter. Sectoral Asset Management Inc now owns 179,152 shares of the company’s stock worth $6,398,000 after buying an additional 45,653 shares during the last quarter. Institutional investors own 46.92% of the company’s stock.
WARNING: “DBV Technologies SA – to Post Q1 2018 Earnings of ($1.03) Per Share, Jefferies Group Forecasts (DBVT)” was originally reported by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.com-unik.info/2017/12/23/dbv-technologies-sa-to-post-q1-2018-earnings-of-1-03-per-share-jefferies-group-forecasts-dbvt.html.
DBV Technologies Company Profile
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company’s therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin.
Receive News & Ratings for DBV Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DBV Technologies and related companies with MarketBeat.com's FREE daily email newsletter.